Commentary|Videos|June 15, 2025
Strengthening Duchenne Care Through Clinical Collaboration and Community Focus: Brenda L. Wong, MD
Fact checked by: Marco Meglio
The director of the DMD Program at UMass Chan Medical School shared her experience at the 2025 CureDuchenne FUTURES National Conference, held May 22-25, in San Antonio, Texas. [WATCH TIME: 5 minutes]
Advertisement
WATCH TIME: 5 minutes
"Close to my heart is clinical care. And I would say that at the conference, we have seen the sessions for clinical care grow into topics that really meet the needs of our Duchenne and Becker community.”
The 2025 CureDuchenne FUTURES National Conference, held May 22–25 in San Antonio, Texas, provided educational sessions and community engagement opportunities for patients and families affected by Duchenne and Becker muscular dystrophy. The event featured presentations from experts across research, health care, and biotechnology, covering current developments in the field. In addition to scientific updates, the conference included programming tailored to various family experiences, including sessions for newly diagnosed individuals, single parents, siblings, adults with Duchenne, and those managing behavioral challenges.1
Building on its commitment to advancing care for the Duchenne and Becker community, CureDuchenne recently announced the appointment of neuromuscular expert Brenda Wong, MD, as its new chief medical advisor, effective January 5, 2026. In her new role, the organization noted that Wong will guide clinical strategies, collaborate with industry partners on trial design, and contribute to the development of care standards that reflect the evolving needs of patients and families. She recently attended the 2025 FUTURES National Conference, where she lead sessions on clinical care, therapeutic innovation, and support for women and families affected by dystrophinopathies.2
Following the conference, Wong, director of the DMD Program at UMass Chan Medical School, sat down with NeurologyLive® to reflect on the impact and evolution of the CureDuchenne’s FUTURES conference. She noted the growing attention to adult patients with Duchenne, the increasing focus on independence, and the need for tailored support for carriers, particularly mothers and sisters. Brenda also discussed the expanding role of care teams and the shift toward comprehensive, family-centric care models. As she transitions into a new advisory role, she expressed enthusiasm for contributing her experience to education, clinic development, and care innovation in the neuromuscular field.
REFERENCES
1. Global Nonprofit CureDuchenne to Host FUTURES National Conference for the Duchenne and Becker Muscular Dystrophy Community on May 22-25 in San Antonio, TX . News Release. CureDuchenne. Published April 17, 2025. Accessed June 13, 2025. https://cureduchenne.org/press-release/global-nonprofit-cureduchenne-to-host-futures-national-conference-for-the-duchenne-and-becker-muscular-dystrophy-community-on-may-22-25-in-san-antonio-tx/
2. CureDuchenne Appoints Brenda Wong, MD, as Chief Medical Advisor to Advance Research and Improve Care for Individuals with Duchenne and Becker. News Release. CureDuchenne. Published May 21, 2025. Accessed June 13, 2025. https://cureduchenne.org/press-release/cureduchenne-appoints-brenda-wong-md-aschief-medical-advisor-to-advance-research-and-improve-care-for-individuals-with-duchenne-and-becker-muscular-dystrophy
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Related Articles
NeurologyLive® Brain Games: September 14, 2025September 14th 2025
NeurologyLive® Friday 5 — September 12, 2025September 12th 2025
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive
1
MDA and PPMD Release Consensus Guidelines for Safe and Equitable Use of Gene Therapy in Duchenne
2
NeurologyLive® Brain Games: September 14, 2025
3
10 Years of the Women Neurologists Group: A Preview of the 4th Annual Conference
4
